Diabetes mellitus, insulin resistance, and metabolic syndrome in HIV-positive patients in South India

Figures & data

Table 1 Comparison between ART-treated and ART-naïve groups

Study characteristic	ART (n = 30)		ART-naïve (n = 30)		P value
	Mean	SD	Mean	SD
Age (years)	41.63	10.94	40.60	9.48	0.697
Duration of disease (months)	53.03	27.76	17.20	9.18	<0.001
Male/female	23/7	–	21/9	–	–
BMI (kg/m^2)	20.27	3.82	18.41	4.27	0.080+
Waist circumference (cm)	82.7	11.88	76.7	9.64	0.036
Systolic BP (mm Hg)	125.67	18.51	114.13	11.60	0.005
Diastolic BP (mm Hg)	80.60	9.13	75.60	8.23	0.030
Fasting blood glucose (mg/dL)	95	25.16	89.53	19.6	0.352
Two-hour OGTT blood glucose (mg/dL)	111.33	58.47	131.33	28.55	0.094
HOMA	2.50	2.68	1.80	1.93	0.265
Total cholesterol (mg/dL)	157.47	43.58	149.17	39.92	0.445
HDL cholesterol (mg/dL)	32.87	13.27	25.53	9.42	0.017
LDL cholesterol (mg/dL)	86.92	32.91	78.50	21.63	0.281
Triglycerides (mg/dL)	201.37	163.66	155.43	70.14	0.163
CD-4 counts (cells/μL)	210.23	172.89	170.67	131.40	0.322

Abbreviations: ART, antiretroviral therapy; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; HOMA, homeostasis assessment; LDL, low-density lipoprotein; OGTT, oral glucose tolerance test; SD, standard deviation.

Figure 1 Numbers of patients versus criteria for metabolic syndrome.

Notes:

ART-naïve;

ART-treated.

Figure 2 Distribution of criteria among patients with metabolic syndrome.

Notes:

parameter present;

parameter absent.
Abbreviations: BP, blood pressure; FBS, fasting blood sugar; HDL, high-density lipoprotein; TG, triglycerides.